Shu Xu
- Pharmacology top 5%
- Molecular Biology
- Organic Chemistry top 10%
- Pharmacology top 5%
- Immunology
- Co-authors
- Lawrence J. MarnettCarol A. RouzerSurajit BanerjeeKebreab GhebreselasieRen Xiang TanHui DingHui Ming GeMax O. Funk
- Topics
- Inflammatory mediators and NSAID effects (11 papers)Microbial Natural Products and Biosynthesis (4 papers)Cannabis and Cannabinoid Research (4 papers)
- Cited by
- PharmacologyOrganic Chemistry
- Partner nations
- United StatesChinaCuba
In The Last Decade
Shu Xu
36 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 111
- Pharmacology 347
- Molecular Biology 334
- Organic Chemistry 323
- Pharmacology 92
- Immunology 85
Countries citing papers authored by Shu Xu
This map shows the geographic impact of Shu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Xu more than expected).
Fields of papers citing papers by Shu Xu
This network shows the impact of papers produced by Shu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Xu. The network helps show where Shu Xu may publish in the future.
Co-authorship network of co-authors of Shu Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Shu Xu. A scholar is included among the top collaborators of Shu Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Xu. Shu Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 6 | |
| 3 | 16 | |
| 4 | 34 | |
| 5 | 20 | |
| 6 | 11 | |
| 7 | 30 | |
| 8 | 31 | |
| 9 | 29 | |
| 10 | 1 | |
| 11 | 25 | |
| 12 | 8 | |
| 13 | 15 | |
| 14 | 37 | |
| 15 | 101 | |
| 16 | 21 | |
| 17 | 14 | |
| 18 | 81 | |
| 19 | 18 | |
| 20 | 5 |
About Shu Xu
Shu Xu is a scholar working on Pharmacology, Toxicology and Pharmacology, having authored 36 papers that have together received 1.0k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (11 papers), Microbial Natural Products and Biosynthesis (4 papers) and Cannabis and Cannabinoid Research (4 papers). The work is most often cited by research in Pharmacology (347 citations), Organic Chemistry (323 citations) and Pharmacology (92 citations). Shu Xu has collaborated with scholars based in United States, China and Cuba. Frequent co-authors include Lawrence J. Marnett, Carol A. Rouzer, Surajit Banerjee, Kebreab Ghebreselasie, Ren Xiang Tan, Hui Ding, Hui Ming Ge, Max O. Funk, Jun‐Yan Liu and Rui Jiao. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.